These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35785302)

  • 1. Apoferritin-Encapsulated Jerantinine A for Transferrin Receptor Targeting and Enhanced Selectivity in Breast Cancer Therapy.
    Abuzaid H; Abdelrazig S; Ferreira L; Collins HM; Kim DH; Lim KH; Kam TS; Turyanska L; Bradshaw TD
    ACS Omega; 2022 Jun; 7(25):21473-21482. PubMed ID: 35785302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of Temozolomide and N3-Propargyl Analog to Brain Tumors Using an Apoferritin Nanocage.
    Bouzinab K; Summers HS; Stevens MFG; Moody CJ; Thomas NR; Gershkovich P; Weston N; Ashford MB; Bradshaw TD; Turyanska L
    ACS Appl Mater Interfaces; 2020 Mar; 12(11):12609-12617. PubMed ID: 32073826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells.
    Quilles Junior JC; Carlos FDRR; Montanari A; Leitão A; Mignone VW; Arruda MA; Turyanska L; Bradshaw TD
    RSC Adv; 2019 Nov; 9(63):36699-36706. PubMed ID: 35539052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery.
    Breen AF; Scurr D; Cassioli ML; Wells G; Thomas NR; Zhang J; Turyanska L; Bradshaw TD
    Int J Nanomedicine; 2019; 14():9525-9534. PubMed ID: 31824148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel apoferritin formulations for antitumour benzothiazoles.
    Breen AF; Wells G; Turyanska L; Bradshaw TD
    Cancer Rep (Hoboken); 2019 Aug; 2(4):e1155. PubMed ID: 32721126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of apoptotic activities on brain cancer cells via the combination of γ-tocotrienol and jerantinine A.
    Abubakar IB; Lim KH; Kam TS; Loh HS
    Phytomedicine; 2017 Jul; 30():74-84. PubMed ID: 28545672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel antitumour indole alkaloid, Jerantinine A, evokes potent G2/M cell cycle arrest targeting microtubules.
    Raja VJ; Lim KH; Leong CO; Kam TS; Bradshaw TD
    Invest New Drugs; 2014 Oct; 32(5):838-50. PubMed ID: 24927857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoferritin-encapsulated PbS quantum dots significantly inhibit growth of colorectal carcinoma cells.
    Bradshaw TD; Junor M; Patanè A; Clarke P; Thomas NR; Li M; Mann S; Turyanska L
    J Mater Chem B; 2013 Dec; 1(45):6254-6260. PubMed ID: 32261698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical studies with JAA-F11 anti-Thomsen-Friedenreich monoclonal antibody for human breast cancer.
    Ferguson K; Yadav A; Morey S; Abdullah J; Hrysenko G; Eng JY; Sajjad M; Koury S; Rittenhouse-Olson K
    Future Oncol; 2014 Feb; 10(3):385-99. PubMed ID: 24559446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11.
    Heimburg J; Yan J; Morey S; Glinskii OV; Huxley VH; Wild L; Klick R; Roy R; Glinsky VV; Rittenhouse-Olson K
    Neoplasia; 2006 Nov; 8(11):939-48. PubMed ID: 17132226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis.
    Tati S; Fisk JC; Abdullah J; Karacosta L; Chrisikos T; Philbin P; Morey S; Ghazal D; Zazala F; Jessee J; Quataert S; Koury S; Moreno D; Eng JY; Glinsky VV; Glinskii OV; Sesay M; Gebhard AW; Birthare K; Olson JR; Rittenhouse-Olson K
    Neoplasia; 2017 Sep; 19(9):716-733. PubMed ID: 28830009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Self-Targeting, Dual ROS/pH-Responsive Apoferritin Nanocage for Spatiotemporally Controlled Drug Delivery to Breast Cancer.
    Du B; Jia S; Wang Q; Ding X; Liu Y; Yao H; Zhou J
    Biomacromolecules; 2018 Mar; 19(3):1026-1036. PubMed ID: 29455519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
    Gupta P; Srivastava SK
    BMC Med; 2012 Jul; 10():80. PubMed ID: 22824293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction to "Apoferritin-Encapsulated Jerantinine A for Transferrin Receptor Targeting and Enhanced Selectivity in Breast Cancer Therapy".
    Abuzaid H; Abdelrazig S; Ferreira L; Collins HM; Kim DH; Lim KH; Kam TS; Thomas NR; Turyanska L; Bradshaw TD
    ACS Omega; 2024 Jan; 9(1):2012. PubMed ID: 38222495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src regulates Tyr(20) phosphorylation of transferrin receptor-1 and potentiates breast cancer cell survival.
    Jian J; Yang Q; Huang X
    J Biol Chem; 2011 Oct; 286(41):35708-35715. PubMed ID: 21859709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of hypocrellin B nanocages in self-assembled apoferritin for enhanced intracellular uptake and photodynamic activity.
    Jiang Y; Pang X; Wang X; Leung AW; Luan Y; Zhao G; Wang P; Xu C
    J Mater Chem B; 2017 Mar; 5(10):1980-1987. PubMed ID: 32263952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging.
    Karacosta LG; Fisk JC; Jessee J; Tati S; Turner B; Ghazal D; Ludwig R; Johnson H; Adams J; Sajjad M; Koury S; Roy R; Olson JR; Rittenhouse-Olson K
    Transl Oncol; 2018 Apr; 11(2):450-466. PubMed ID: 29477636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suberoylanilide hydroxamic acid as a potential therapeutic agent for human breast cancer treatment.
    Huang L; Pardee AB
    Mol Med; 2000 Oct; 6(10):849-66. PubMed ID: 11126200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platycodin D from Platycodonis Radix enhances the anti-proliferative effects of doxorubicin on breast cancer MCF-7 and MDA-MB-231 cells.
    Tang ZH; Li T; Gao HW; Sun W; Chen XP; Wang YT; Lu JJ
    Chin Med; 2014; 9():16. PubMed ID: 24982689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panitumumab-DOTA-
    Facca VJ; Cai Z; Gopal NEK; Reilly RM
    Mol Pharm; 2022 Oct; 19(10):3652-3663. PubMed ID: 35926098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.